India Rejects Patent Bid For Drug-Resistant TB Treatment Regimen - Editorial photo report on drug-resistant TB treatment
Jobs & Careers

India Rejects Patent Bid For Drug-Resistant TB Treatment Regimen

India rejects TB Alliance’s patent bid for the BPaL drug-resistant tuberculosis regimen, marking a massive victory for global health access.

Latest Articles